JP4368250B2 - Post-form dosage form of warm cosmetic - Google Patents
Post-form dosage form of warm cosmetic Download PDFInfo
- Publication number
- JP4368250B2 JP4368250B2 JP2004170884A JP2004170884A JP4368250B2 JP 4368250 B2 JP4368250 B2 JP 4368250B2 JP 2004170884 A JP2004170884 A JP 2004170884A JP 2004170884 A JP2004170884 A JP 2004170884A JP 4368250 B2 JP4368250 B2 JP 4368250B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- cosmetic
- post
- glycerin
- dosage form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 89
- 239000002552 dosage form Substances 0.000 title claims description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 70
- -1 fatty acid esters Chemical class 0.000 claims description 40
- 235000011187 glycerol Nutrition 0.000 claims description 36
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 21
- 229940105990 diglycerin Drugs 0.000 claims description 20
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 17
- 239000000194 fatty acid Substances 0.000 claims description 17
- 229930195729 fatty acid Natural products 0.000 claims description 17
- 238000010792 warming Methods 0.000 claims description 17
- 238000005187 foaming Methods 0.000 claims description 14
- 239000001282 iso-butane Substances 0.000 claims description 10
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 7
- 229920000223 polyglycerol Polymers 0.000 claims description 6
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 2
- 229960003720 enoxolone Drugs 0.000 claims description 2
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 1
- 239000006260 foam Substances 0.000 description 29
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 20
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 18
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 16
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 9
- 240000000912 Macadamia tetraphylla Species 0.000 description 9
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 9
- 235000021355 Stearic acid Nutrition 0.000 description 9
- 229960000735 docosanol Drugs 0.000 description 9
- 239000004973 liquid crystal related substance Substances 0.000 description 9
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 9
- 239000010466 nut oil Substances 0.000 description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 9
- 229940032094 squalane Drugs 0.000 description 9
- 239000008117 stearic acid Substances 0.000 description 9
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 9
- 229920001285 xanthan gum Polymers 0.000 description 9
- 235000010493 xanthan gum Nutrition 0.000 description 9
- 239000000230 xanthan gum Substances 0.000 description 9
- 229940082509 xanthan gum Drugs 0.000 description 9
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 8
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 8
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 8
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 8
- 229940105017 achillea millefolium extract Drugs 0.000 description 8
- 229940099417 ceramide 2 Drugs 0.000 description 8
- 235000010389 delta-tocopherol Nutrition 0.000 description 8
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 8
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 8
- 229960002216 methylparaben Drugs 0.000 description 8
- 229960005323 phenoxyethanol Drugs 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000002446 δ-tocopherol Substances 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000006096 absorbing agent Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 5
- 150000004665 fatty acids Chemical group 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000020169 heat generation Effects 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- JROIJWFERXRNAH-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC(C)C)(=O)O.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO Chemical compound C(CCCCCCCCCCCCCCC(C)C)(=O)O.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO JROIJWFERXRNAH-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- DEHSROIMLHSKQK-PDTZROCYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O DEHSROIMLHSKQK-PDTZROCYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UBFZCDAKYBGKGF-UHFFFAOYSA-N octadecanoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O UBFZCDAKYBGKGF-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 125000005314 unsaturated fatty acid group Chemical group 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
本発明は、化粧料に関し、更に詳細には、ポスト・フォーム剤形の温感化粧料に好適な化粧料に関する。 The present invention relates to a cosmetic, and more particularly to a cosmetic suitable for a post - form dosage form of a warm cosmetic.
化粧料を塗布する行為に於いて、その化粧料がどの様な温度刺激をもたらすかが、化粧料の効果に大きな影響を与えることが、化粧料の研究者達の近年の検討で明らかにされている。即ち、マッサージやパックの行為に於いて、化粧料の塗布が冷感刺激をもたらすような場合には、その効果が著しく減じてしまう欠点が見出され、これを克服する手段として温感付与化粧料が開発されている。前記温感付与化粧料としては、例えば、ゼオライトや多価アルコールを含有させて、これらの成分が水和する際に生じる水和熱を利用するもの(例えば、特許文献1を参照)、二重容器に互いに反応して発熱する成分をそれぞれ孤立させて収納し、吐出時に剪断力を利用して、これらの成分を混合、反応させ、反応熱を発生させる製剤(例えば、特許文献2を参照)或いは使用時に金属酸化物と有機酸とを反応させて反応熱を発生させる方法(例えば、特許文献3を参照)等が存する。 In recent years, cosmetic researchers have revealed that what kind of temperature stimulation the cosmetics bring in the act of applying the cosmetics has a great influence on the effect of the cosmetics. ing. In other words, in the act of massage or pack, when the application of cosmetics causes a cooling sensation, the disadvantage that the effect is remarkably reduced is found. Fees have been developed. Examples of the warm feeling-imparting cosmetics include zeolite and polyhydric alcohol, which utilize heat of hydration generated when these components are hydrated (for example, see Patent Document 1), double A formulation that generates heat of reaction by mixing and reacting these components using a shearing force at the time of discharge by isolating and storing the components that generate heat by reacting with each other in a container (see, for example, Patent Document 2) Alternatively, there is a method of generating reaction heat by reacting a metal oxide and an organic acid during use (for example, see Patent Document 3).
一方、ポスト・フォーム剤形の化粧料は、吐出時は通常の化粧料であり、これを塗布するなど化粧行為を行う過程で徐々に発泡する剤形の化粧料であるが、このものは通常の化粧料の使用感触と、フォーム化粧料の使用感触とを兼ね備えたものであり、優れた使用特性を有し、この為、この剤形のマッサージ化粧料やパック化粧料が開発されている(例えば、特許文献4、特許文献5、特許文献6を参照)。しかしながら、温感化粧料であって、且つ、ポスト・フォーム剤形の化粧料は全く知られていない。更に、温感剤形とすることで、マッサージ化粧料としての機能、パック化粧料としての機能が高まることは知られていない。又、この様な従来のポスト・フォーム剤形では、ウォッシュオフ性能は付与されていないのが常であり、ウォッシュオフ特性を有するポスト・フォーム剤形は全く知られていない。 On the other hand, post-foam dosage form of cosmetics, at the time of discharge is a normal cosmetic, but is gradually cosmetic composition of the foam dosage form in the process of performing a cosmetic action, such as to apply it, this thing is usually It has both the feeling of use of cosmetics and the feeling of use of foam cosmetics, and has excellent usage characteristics. Therefore, massage cosmetics and pack cosmetics of this dosage form have been developed ( for example, refer to Patent Document 4, Patent Document 5, Patent Document 6). However, there are no known warm cosmetics and post-form dosage forms . Furthermore, it is not known that the function as a massage cosmetic and the function as a pack cosmetic are enhanced by adopting a warm sensation form. Further, such conventional post-foam dosage forms usually do not have wash-off performance, and no post-foam dosage forms having wash-off characteristics are known at all.
高粘度組成物を押し出すためのエアゾール容器として、移動可能かつ内容物を分離可能な隔壁によって分離された二室容器内部の一方の空間部に吐出される内容物が充填され、他方の空間部に、前記内容物を押し出すために加圧する圧縮ガスが充填されたエアゾール製剤が開発されている。これが所謂ダブルチャンバータイプ(2室形態)のエアゾール容器である(例えば、特許文献7、特許文献8、特許文献9、特許文献10、特許文献11、特許文献12、特許文献13、特許文献14、特許文献15,特許文献16を参照)。かかる技術により、かなり粘度の高い内容物の吐出、或いは、ポスト・フォーム剤形で最後まで発泡力の低下しない内容物の吐出が可能になっていることを、本発明者は確認した。 As an aerosol container for extruding a high-viscosity composition, the content discharged into one space part inside the two-chamber container separated by a partition wall that is movable and can separate the contents is filled, and the other space part is filled An aerosol formulation filled with compressed gas that is pressurized to extrude the contents has been developed. This is a so-called double chamber type (two-chamber form) aerosol container (for example, Patent Document 7, Patent Document 8, Patent Document 9, Patent Document 10, Patent Document 11, Patent Document 12, Patent Document 13, Patent Document 14, Patent Document 15, see Patent Document 16). The present inventor has confirmed that such a technique enables the discharge of contents with a considerably high viscosity or the discharge of contents that do not decrease in foaming power to the end in a post-foam dosage form.
本発明は、この様な状況下為されたものであり、ポスト・フォーム剤形の化粧料に新規効果を付与する技術を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a technique for imparting a novel effect to a post-form dosage form cosmetic.
この様な状況に鑑みて、本発明者らは、ポスト・フォーム剤形の化粧料に新規効果を付与する技術を求めて、鋭意研究努力を重ねた結果、1)グリセリン及びジグリセリンから選ばれる成分の合計含有量が45〜60質量%であり、2)ポリグリセリンの脂肪酸エステルの含有量が2〜10質量%であり、3)水の含有量が10〜25質量%であり、且つ、4)発泡用のガスの含有量が1〜2質量%である、ポスト・フォーム剤形の化粧料であって、グリセリンの含有量が、前記グリセリン及びジグリセリンから選ばれる成分の合計含有量の90質量%以上であることを特徴とする、ポスト・フォーム剤形の温感化粧料が、優れた温感効果を有し、これをパック化粧料等に応用した場合、リラクゼーション効果を高め、以てパックの肌へ与える効果が著しくなることを見出し、発明を完成させるに至った。即ち、本発明は、以下に示す通りである。
(1)1)グリセリン及びジグリセリンから選ばれる成分の合計含有量が45〜60質量%であり、2)ポリグリセリンの脂肪酸エステルの含有量が2〜10質量%であり、3)水の含有量が10〜25質量%であり、且つ、4)発泡用のガスの含有量が1〜2質量%であることを特徴とする、ポスト・フォーム剤形の温感化粧料であって、
グリセリンの含有量が、前記グリセリン及びジグリセリンから選ばれる成分の合計含有量の90質量%以上であることを特徴とする、ポスト・フォーム剤形の温感化粧料。
(2)前記発泡用のガスが、イソブタンのみ、又はノルマルブタンとイソブタンの混合物であり、ノルマルブタン:イソブタン=1:4〜0:10の割合であることを特徴とする、(1)に記載の温感化粧料。
(3)グリチルリチン酸及びその塩並びにグリチルレチン酸アルキルエステルから選択される1種乃至2種以上を0.03〜1質量%含有することを特徴とする、(1)又は(2)に記載の温感化粧料。
In view of such circumstances, the present inventors have found that, in search of technology to grant a new effect in the post-form dosage form of cosmetics, the results of extensive research efforts, 1) selected from the group consisting of glycerin及beauty diglycerol the total content of the components is 45 to 60 wt%, 2) a content of fatty acid esters of polyglycerol 2-10 wt%, 3) is 25 wt% content of 10 of water, and 4 ) Post-foam dosage form cosmetics in which the foaming gas content is 1 to 2% by mass , wherein the glycerin content is the total content of the components selected from the glycerin and diglycerin. 90% by mass or more of the post-form dosage form of warm cosmetics has an excellent warm feeling effect, and when applied to pack cosmetics, etc., the relaxation effect is enhanced, Therefore, it gives to the skin of the pack And the inventors have found that the effect is remarkable. That is, the present invention is as follows.
(1) 1) the total content of components selected from glycerin及beauty diglycerin is 45 to 60 wt%, 2) the content of the fatty acid esters of polyglycerol is 2 to 10 wt%, 3) water 4 ) A warm cosmetic for a post-form dosage form, characterized in that the content is 10 to 25 % by mass, and 4 ) the content of the foaming gas is 1 to 2% by mass ,
A post-form dosage form of a warm cosmetic, wherein the glycerin content is 90% by mass or more of the total content of the components selected from the glycerin and diglycerin.
(2) the foaming gas is isobutane alone or butane and mixtures isobutane, normal butane: isobutane = 1: 4:00 to 0:10 and wherein the ratio der Rukoto of, (1) The warm cosmetics described.
(3), characterized in that it contains 0.03 to 1 wt% of one or two or more selected from glycyrrhizic acid and its salts and glycyrrhetinic acid alkyl esters, as described in (1) or (2) temperature Feeling cosmetics.
本発明によれば、ポスト・フォーム剤形の化粧料に新規効果を付与する技術を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the technique which provides a novel effect to the cosmetics of a post-form dosage form can be provided.
(1)本発明の温感化粧料の必須成分であるグリセリン及び/又はジグリセリン
本発明の温感化粧料は、ポスト・フォーム剤形であってグリセリン及び/又はジグリセリンを45〜60質量%、より好ましくは50〜58質量%含有することを特徴とする。かかる成分は、皮膚上に投与した場合に於いて皮膚上の水分と水和して発熱し、温熱効果を発揮する。又、後記のポリグリセリンの脂肪酸エステルとともに液晶を形成し、水との水和速度を調整し発熱の特性を調整する作用を有する。又、液晶を形成することにより、フォームを形成するのに必要な油性成分を水のみで除去することが出来る、ウォッシュオフ作用を発揮する。本発明の温感化粧料に於いて、グリセリン及び/又はジグリセリンは、どちらか一種を含有させることも出来るし、両者を併用して含有させることも出来る。特に好ましい形態は、両者を含有し、且つ、グリセリンの含有量が、グリセリン及びジグリセリン含有量の90質量%以上、より好ましくは93質量%以上である形態である。この形態を採ることにより、水和熱の発生制御と、液晶の安定性向上が為しうる。
(1) warming cosmetic of an essential component of the warming cosmetic is glycerin and / or diglycerin invention of the present invention is a post-foam dosage form glycerin and / or diglycerin 45 to 60 wt% More preferably, it contains 50 to 58% by mass. Such components, when administered on the skin, hydrate with the moisture on the skin to generate heat and exert a thermal effect. In addition, it forms a liquid crystal together with the polyglycerol fatty acid ester described later, and has the effect of adjusting the hydration rate with water and adjusting the heat generation characteristics. Further, by forming the liquid crystal, the oily component necessary for forming the foam can be removed only with water, and a wash-off action is exhibited. In the warm cosmetic composition of the present invention, either glycerin and / or diglycerin can be contained, or both can be contained in combination. A particularly preferred form is a form containing both, and the glycerin content is 90% by mass or more, more preferably 93% by mass or more of the glycerin and diglycerin content. By adopting this form, it is possible to control the generation of heat of hydration and improve the stability of the liquid crystal.
(2)本発明の温感化粧料の必須成分である水
本発明の温感化粧料は、ポスト・フォーム剤形であって、水を25質量%以下、より詳細には、5〜25質量%、より好ましくは、5〜23質量%含有することを特徴とする。本発明の温感化粧料に於いて。水は液晶を含む系の安定化と、ウォッシュオフ機能の創出に働く。水が少なすぎると、安定な液晶を含む系が形成せず、発熱の調整が困難になり、心地よい温感を提供できない場合、或いは、ウォッシュオフしにくい場合が存し、多すぎると、液晶系からエマルション系に移行し、発熱が調整しにくくなったり、発熱量そのものが低下する場合が存する。取り分け、本発明の温感化粧料をウオッシュオフ可能なポスト・フォーム剤形の化粧料にする場合に於いては、水の量を10〜25質量%に調整し、ガス以外の内容物を調製した場合に於いて、該内容物の性状を、液晶構造乃至は液晶構造とエマルションの混在系に調整しておくことが好ましい。
(2) is an essential component of the warming cosmetic of the present invention Mizumoto warming cosmetic of the invention, there is provided a post-foam dosage form, water of 25 wt% or less, and more particularly, 5 to 25 mass %, More preferably 5 to 23% by mass. In the warm cosmetic composition of the present invention. Water works to stabilize liquid crystal-containing systems and create a wash-off function. If the amount of water is too small, a system containing a stable liquid crystal will not be formed, and it will be difficult to adjust the heat generation, and a comfortable warm feeling may not be provided, or it may be difficult to wash off. To the emulsion system, it may be difficult to adjust the heat generation, or the heat generation amount itself may decrease. Especially, is at when the cosmetic composition of the wash-off can be post-foam dosage form warming cosmetic of the present invention, the amount of water was adjusted to 10 to 25 wt%, the contents of the non-gas preparation In this case, it is preferable to adjust the properties of the contents to a liquid crystal structure or a mixed system of a liquid crystal structure and an emulsion.
(3)本発明の温感化粧料の必須成分である発泡用のガス
本発明の温感化粧料は、必須成分として発泡用のガスを1〜2質量%、より好ましくは1.1〜1.5質量%含有することを特徴とする。かかるガスとしては、化粧料のエアゾール製剤で使用されているガスであれば特段の限定無く使用することが出来、例えば、フ
ロンのようなフッ化炭化水素類、LPG等の炭化水素類、炭酸ガスなどが好適に例示できる。特に好ましいものは、炭化水素類であり、特に、イソブタンを主体として、発泡性などの要素に鑑みてノルマルブタンを添加するような形態、具体的には、ノルマルブタン:イソブタン=1:4〜0:10、より好ましくは1:6〜0:10の割合の混合物乃至はイソブタンのみを用いることが好ましい。これは、この範囲の混合物を使用することにより、使用感の優れるポスト・フォーム剤形が得られることと、パック化粧料として使用した場合に於いて、ガスに由来する一次刺激が生じにくい為である。又、この特性は本発明のポスト・フォーム剤形の温感化粧料をマッサージ化粧料として用いた場合にも、有益に機能する。
(3) warming cosmetic of an essential component of the warming cosmetic is gas present invention for foaming of the present invention, 1 to 2 wt% of the foaming gas as an essential component, and more preferably 1.1-1 It is characterized by containing 5 mass%. As such a gas, any gas used in cosmetic aerosol preparations can be used without particular limitation. For example, fluorocarbons such as Freon, hydrocarbons such as LPG, and carbon dioxide gas. Etc. can be suitably exemplified. Particularly preferred are hydrocarbons, and in particular, a form in which n-butane is added mainly in view of factors such as foamability, mainly isobutane, specifically n-butane: isobutane = 1: 4-0. : 10, more preferably a mixture of 1: 6 to 0:10 or only isobutane is used. This is because a post-foam dosage form with excellent usability can be obtained by using a mixture in this range, and primary irritation derived from gas is less likely to occur when used as a pack cosmetic. is there. This characteristic also functions beneficially when the post-foam dosage form of the present invention is used as a massage cosmetic .
(4)第二の実施形態であるウォッシュオフ機能を有するポスト・フォーム剤形の温感化粧料
本発明の温感化粧料の第二の実施形態は、第一の実施形態である、ポスト・フォーム剤形の温感化粧料に、ウォッシュオフ機能を付加したものである。この様な機能を付加するためには、第一には、前記の如くに水の量を10〜25質量%に調整しておくことである。加えて、使用する界面活性剤として、ポリグリセリンの脂肪酸エステルを2〜10質量%、より好ましくは3〜5質量%含有させることである。この様な構成を採ることにより、ガスを除く内容物は、液晶乃至は液晶とエマルションの混在系を採る。この様な系にすることにより、水を加えた場合に於いて、油性成分を速やかにエマルションの内部に包含することが出来るため、流水のみによるすすぎによって、化粧料をウォッシュオフすることが出来る。内容物の形態が液晶構造のみの場合には、ウォッシュオフ後、極微量に残存した油性成分により、皮膚がしっとりとする。又、この様な系においても必要にして充分な温熱効果が得られる。前記ポリグリセリンの脂肪酸エステルとしては、グリセリンの重合度が5〜15のものが好ましく、且つ、遊離の水酸基を6〜15個有するものが好ましい。又,脂肪酸残基(アシル基)としては、炭素数12〜20の飽和又は不飽和の脂肪酸残基が好ましく、飽和の脂肪酸残基としては、直鎖脂肪酸残基であっても分岐脂肪酸残基であっても良い。具体的に、好ましいポリグリセリンの脂肪酸エステルを例示すれば、ペンタグリセリンモノステアレート、ペンタグリセリンモノオレート,ペンタグリセリンモノイソステアレート、オクタグリセリンモノステアレート、オクタグリセリンモノオレート、オクタグリセリンモノイソステアレート、デカグリセリンモノラウレート、デカグリセリンモノステアレート、デカグリセリンモノオレート、デカグリセリンモノイソステアレート、デカグリセリントリラウレート、デカグリセリントリステアレート、デカグリセリントリイソステアレート、デカグリセリントリオレート等が例示でき、デカグリセリンモノオレートとデカグリセリントリステアレートが特に好ましく、これらを1:2〜2:1で組み合わせて使用することが特に好ましい。
(4) Second embodiment of the warming cosmetic of warming cosmetic present invention post-form the dosage form having a wash-off function which is a second embodiment is the first embodiment, post A foam-type warm cosmetic with a wash-off function. In order to add such a function, first, the amount of water is adjusted to 10 to 25% by mass as described above. In addition, the surfactant to be used is to contain a fatty acid ester of polyglycerol of 2 to 10% by mass, more preferably 3 to 5% by mass. By adopting such a configuration, content excluding gas, liquid or takes a mixed system of a liquid crystal and an emulsion. With such a system, when water is added, the oily component can be quickly included in the emulsion, so that the cosmetic can be washed off by rinsing with running water alone. When the form of the content is only a liquid crystal structure, the skin is moistened by the oily component remaining in a trace amount after the wash-off. In addition, sufficient thermal effect is obtained in need even in such a system. As the polyglycerol fatty acid ester, those having a polymerization degree of glycerol of 5 to 15 are preferable, and those having 6 to 15 free hydroxyl groups are preferable. The fatty acid residue (acyl group) is preferably a saturated or unsaturated fatty acid residue having 12 to 20 carbon atoms, and the saturated fatty acid residue is a branched fatty acid residue even if it is a linear fatty acid residue. It may be. Specifically, preferred examples of the fatty acid ester of polyglycerin include pentaglycerin monostearate, pentaglycerin monooleate, pentaglycerin monoisostearate, octaglycerin monostearate, octaglycerin monooleate, octaglycerin monoisostearate. , Decaglycerin monolaurate, decaglycerin monostearate, decaglycerin monooleate, decaglycerin monoisostearate, decaglycerin trilaurate, decaglycerin tristearate, decaglycerin triisostearate, decaglycerin trioleate, etc. Decaglycerin monooleate and decaglycerin tristearate are particularly preferable, and it is particularly preferable to use them in a combination of 1: 2 to 2: 1.
(5)本発明の温感化粧料
本発明の温感化粧料は、ポスト・フォーム剤形であって、前記の成分を必須成分として含有することを特徴とする。本発明の温感化粧料に於いては、前記の必須成分以外に、本発明の効果を損なわない範囲に於いて、通常化粧料で使用される任意の成分を含有するこ
とが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類、流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類、オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等、イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン、アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類、脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類、塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類、イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類、ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類、ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキシレングリコール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類、ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類、グアガム、クインスシード、カラギーナン、ガラクタン、アラビアガム、ペクチン、マンナン、デンプン、キサンタンガム、カードラン、メチルセルロース、ヒドロキシエチルセルロース、カルボキシメチルセルロース、メチルヒドロキシプロピルセルロース、コンドロイチン硫酸、デルマタン硫酸、グリコーゲン、ヘパラン硫酸、ヒアルロン酸、ヒアルロン酸ナトリウム、トラガントガム、ケラタン硫酸、コンドロイチン、ムコイ
チン硫酸、ヒドロキシエチルグアガム、カルボキシメチルグアガム、デキストラン、ケラト硫酸,ローカストビーンガム,サクシノグルカン,カロニン酸,キチン,キトサン、カルボキシメチルキチン、寒天、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸ナトリウム、ポリエチレングリコール、ベントナイト等の増粘剤、表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類、表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類、レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類、ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類、パラアミノ安息香酸系紫外線吸収剤、アントラニル酸系紫外線吸収剤、サリチル酸系紫外線吸収剤、桂皮酸系紫外線吸収剤、ベンゾフェノン系紫外線吸収剤、糖系紫外線吸収剤、2−(2'−ヒドロキシ−5'−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4'−t−ブチルジベンゾイルメタン等の紫外線吸収剤類、エタノール、イソプロパノール等の低級アルコール類、ビタミンA又はその誘導体、ビタミンB6塩酸塩,ビタミンB6トリパルミテート,ビタミンB6ジオクタノエート,ビタミンB2又はその誘導体,ビタミンB12,ビタミンB15又はその誘導体等のビタミンB類、α−トコフェロール,β−トコフェロール,γ−トコフェロール,ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類などが好ましく例示できる。本発明の温感化粧料は、これらの成分を常法に従って処理することにより、製造することが出来る。
(5) warming cosmetic of warming cosmetic invention of the present invention is a post-foam dosage form, characterized by containing the above components as essential components. In the warm cosmetic composition of the present invention, in addition to the essential components described above, any components that are usually used in cosmetics can be contained within a range not impairing the effects of the present invention. Such optional ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil Oils such as hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, waxes, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax, higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid, cetyl alcohol, stearyl alcohol, isostearyl Alcohol, behenyl alcohol, octyldodecanol, higher alcohol such as myristyl alcohol, cetostearyl alcohol, cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate, dimethylpolysiloxane, methylphenylpoly Loxane, linear polysiloxane such as diphenylpolysiloxane, cyclic polysiloxane such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane, amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oil such as modified polysiloxane such as fluorine-modified polysiloxane, anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfate, chloride Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide, imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyltaurine, sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid ester and alkyl glucoside, polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Polyols such as recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, 1,2-octanediol, pyrrolidone carboxylic acid Moisturizing ingredients such as sodium, lactic acid, sodium lactate, guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate , Dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, mucoitin sulfate, hyaluronan Droxyethyl guar gum, carboxymethyl guar gum, dextran, keratosulfuric acid, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethylchitin, agar, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, sodium polyacrylate, Thickeners such as polyethylene glycol and bentonite, surface may be treated, powder such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (silica), aluminum oxide, barium sulfate The surface may be treated, bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide inorganic pigments, the surface may be treated, mica titanium, Fish phosphorus foil, bismuth oxychloride Pearl agents, which may be raked Red 202, Red 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201 No., Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, and the like, polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer Organic powders such as paraaminobenzoic acid UV absorbers, anthranilic acid UV absorbers, salicylic acid UV absorbers, cinnamic acid UV absorbers, benzophenone UV absorbers, sugar UV absorbers, 2- ( UV of 2'-hydroxy-5'-t-octylphenyl) benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane, etc. Absorbents, lower alcohols such as ethanol and isopropanol, vitamin A or derivatives thereof, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or derivatives thereof, vitamin B12, vitamin B15 or derivatives thereof, etc. Vitamin E such as vitamin B, α-tocopherol, β-tocopherol, γ-tocopherol and vitamin E acetate, vitamin D such as vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone and the like can be preferably exemplified. The warm cosmetic composition of the present invention can be produced by treating these components according to a conventional method.
本発明の温感化粧料は、ポスト・フォーム剤形を採ることから、エアゾール容器に、発泡用のガスとともに封入することが好ましい。この様なエアゾール容器としては、移動可能かつ内容物を分離可能な隔壁によって分離された二室容器を用いることが好ましく、かかる容器の内袋に化粧料と発泡のためのガス成分を充填し、その外側に吐出のためのガスを封入することが好ましい。即ち、本発明の温感化粧料は、前記内容物を二室容器の内袋に充填し、その外部に更に吐出のためのガスを充填してあることを特徴とする。前記内袋の外側に充填するガスとしては、前記内容物に含有される発泡のためのガスよりも、0.05Mpas以上、より好ましくは、0.07Mpas以上圧力が高いことが好ましい。吐出のためのガスも、発泡のためのガスと同様のものを使用することが出来る。この様な二室容器としては、図1に示すものが好ましく例示できる。かくして得られた本発明のポスト・フォーム剤形の温感化粧料は、通常使用されている化粧料には特段の限定無く応用できるが、擦過途中に発泡して感触と機能が変化する点を生かして、マッサージ化粧料乃至はマッサージング・パック化粧料に応用することが好ましい。又、泡による閉塞効果と温熱効果と勘案すれば、パック化粧料に応用することも好ましい。その両者を兼ね備える意味では、マッサージング・パック化粧料に応用することが特に好ましい。ここで、マッサージング・パックとは、ジェル状乃至は乳化物の形態で吐出した組成物を、マッサージ行為として、皮膚上で擦過して発泡させ、発泡後は泡沫の閉塞性を利用してパック化粧料とするような化粧料のことを指す。本発明の温感化粧料では、閉塞効果に加えて、温熱効果も得られる利点が存する。このことから、本発明の温感化粧料に於いては、グリチルリチン酸ジカリウムなどのグリチルリチン或いはその塩、グリチルレチン酸ステアリルなど
のグリチルレチン酸アルキル等の抗炎症剤を0.03〜0.1質量%、より好ましくは、0.04〜0.07質量%含有することが好ましく、その形態に於いて、医薬部外品とすることが、使用法を正確にし、本発明の温感化粧料の効果を高めることから好ましい。医薬部外品に於いては、その使用態様を明確にするために、抗炎症作用を訴求する旨と、1週間に1回乃至は数回、顔面に化粧料を吐出させ、20〜60秒かけて擦過しながら顔面全体に延展し、発泡を確認した後3〜10分静置し、パックする使用形態で使用する旨と、使用時に刺激を感じた場合には速やかに使用を中止し、医師と相談する旨とを、包装形態に表示することが好ましい。
Warming cosmetic of the present invention, since the take post-form the dosage form, the e azole container, it is preferable to encapsulate with the gas for foaming. As such an aerosol container, it is preferable to use a two-chamber container separated by a partition wall that is movable and separable, and the inner bag of such container is filled with a cosmetic and a gas component for foaming, It is preferable to enclose a gas for discharge on the outside. That is, the warm cosmetic of the present invention is characterized in that the content is filled in an inner bag of a two-chamber container, and gas for discharging is further filled outside. The gas filling the outer side of the inner bag is preferably 0.05 M pas or higher, more preferably 0.07 M pas or higher, than the foaming gas contained in the contents. . Gas for the discharge also can be used the same gas for foaming. As such a two-chamber container, the one shown in FIG. 1 can be preferably exemplified. The thus obtained post-foam dosage form of the warm cosmetic composition of the present invention can be applied to a commonly used cosmetic composition without any particular limitation. It is preferably applied to massage cosmetics or massage pack cosmetics . Moreover, it is also preferable to apply to pack cosmetics in consideration of the blocking effect and thermal effect due to foam. In the meaning which combines both, it is especially preferable to apply to massage pack cosmetics. Here, the massaging pack is a gel-like or emulsified composition discharged as a massaging action by rubbing on the skin and foaming. It refers to a cosmetic, such as a cosmetic. In the warm cosmetic composition of the present invention, there is an advantage that a thermal effect is obtained in addition to the blocking effect. From this, in the warm cosmetic of the present invention, 0.03-0.1% by mass of an anti-inflammatory agent such as glycyrrhizin such as dipotassium glycyrrhizinate or a salt thereof, alkyl glycyrrhetinate such as stearyl glycyrrhetinate, more preferably, preferably contains 0.04 to 0.07 mass%, in the form thereof, be quasi-drug is, usage was precisely, the effect of warming the cosmetic of the present invention It is preferable because it is increased. In quasi-drugs, in order to clarify the mode of use, the anti-inflammatory effect is appealed, and cosmetics are discharged to the face once or several times a week for 20 to 60 seconds. Spread over the entire face while rubbing over, leave it for 3 to 10 minutes after confirming foaming, and stop using it immediately if you feel irritation during use, and use it in a packing usage form, It is preferable to display the effect of consultation with a doctor on the packaging form.
以下に、実施例を挙げて、本発明について更に詳細に説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples, but it is needless to say that the present invention is not limited to such examples.
以下に示す処方に従って、本発明のポスト・フォーム剤形の温感化粧料(抗炎症を訴求した医薬部外品)を作成した。即ち、イ、ロ、ハの成分を75℃に加温して、イとロとを混合し、これに攪拌下徐々にハを加え、攪拌冷却し内容物1を得た。これを80gとり、1gのノルマルブタンとイソブタンの1:4の混合ガスとともに、図1に示す二室容器の内袋部に充填、封入し、外袋部に1.2gの混合ガスを充填し、(内袋より0.07Mpas加圧状態)本発明のポスト・フォーム剤形の温感化粧料1とした。 According to the prescription shown below, a post-form dosage form of warm cosmetic (a quasi-drug that promoted anti-inflammatory) of the present invention was prepared. That is, ingredients (a), (b), and (c) were heated to 75 ° C., and (a) and (b) were mixed. Take 80g of this and fill and seal the inner bag part of the two-chamber container shown in FIG. 1 together with 1g of normal butane and isobutane 1: 4 mixed gas, and fill the outer bag part with 1.2g of mixed gas. (Pressurized state of 0.07 M pas from the inner bag) A warm cosmetic 1 of the post-foam dosage form of the present invention was obtained.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 3.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 50.02 質量%
キサンタンガム 0.02 質量%
水 20 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 3.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 50.02% by mass
Xanthan gum 0.02% by mass
20% by mass of water
実施例1と同様に、本発明のポスト・フォーム剤形の温感化粧料2を作成した。 In the same manner as in Example 1, the post-foam dosage form of warm cosmetic 2 according to the present invention was prepared.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 8.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 50.02 質量%
キサンタンガム 0.02 質量%
水 15 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 8.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 50.02% by mass
Xanthan gum 0.02% by mass
15% by mass of water
実施例1と同様に、本発明のポスト・フォーム剤形の温感化粧料3を作成した。 In the same manner as in Example 1, a post-foam dosage form of the warm cosmetic 3 was prepared.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 3.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 45.02 質量%
キサンタンガム 0.02 質量%
水 25 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 3.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 45.02 mass%
Xanthan gum 0.02% by mass
25% by mass of water
実施例1と同様に、本発明のポスト・フォーム剤形の温感化粧料4を作成した。 In the same manner as in Example 1, the post-foam dosage form of the warm cosmetic 4 of the present invention was prepared.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 3.5 質量%
デカグリセリントリステアレート 4.22 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 50.02 質量%
キサンタンガム 0.02 質量%
水 20 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 3.5% by mass
Decaglycerin tristearate 4.22% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 50.02% by mass
Xanthan gum 0.02% by mass
20% by mass of water
実施例1と同様に、本発明のポスト・フォーム剤形の温感化粧料5を作成した。 In the same manner as in Example 1, a warm cosmetic 5 in the form of a post foam of the present invention was prepared.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 3.5 質量%
デカグリセリンモノオレート 4.22 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 50.02 質量%
キサンタンガム 0.02 質量%
水 20 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 3.5% by mass
Decaglycerin monooleate 4.22% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 50.02% by mass
Xanthan gum 0.02% by mass
20% by mass of water
<比較例1>
以下に示す処方に従って、グリセリンとジグリセリンの量を調整して、実施例1と同様に比較例1のポスト・フォーム剤形の温感化粧料を作成した。
<Comparative Example 1>
According to the prescription shown below, the amount of glycerin and diglycerin was adjusted, and the warm cosmetic of the post-form dosage form of the comparative example 1 was created similarly to Example 1.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 58.52 質量%
キサンタンガム 0.02 質量%
水 15 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 58.52% by mass
Xanthan gum 0.02% by mass
15% by mass of water
<比較例2>
比較例1と同様に、グリセリンとジグリセリンの量を調整して比較例2を作成した。
<Comparative example 2>
As in Comparative Example 1, Comparative Example 2 was prepared by adjusting the amounts of glycerin and diglycerin.
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
1,3−ブタンジオール 18.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 35.02 質量%
キサンタンガム 0.02 質量%
水 20 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
1,3-butanediol 18.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 35.02 mass%
Xanthan gum 0.02% by mass
20% by mass of water
<比較例3>
比較例1と同様に、水分の含有量を調整して、比較例3のポスト・フォーム剤形の温感化粧料を得た。
<Comparative Example 3>
In the same manner as in Comparative Example 1, the moisture content was adjusted to obtain a post-foam dosage form warm cosmetic composition of Comparative Example 3 .
イ)
水添レシチン 0.3 質量%
セラミド2 0.1 質量%
セイヨウノコギリソウエキス 0.1 質量%
POE(20)ベヘニルエーテル 0.5 質量%
デカグリセリントリステアレート 2.22 質量%
デカグリセリンモノオレート 2 質量%
メチルパラベン 0.2 質量%
フェノキシエタノール 0.5 質量%
グリセリン 2 質量%
ロ)
スクワラン 3 質量%
「エルデューPS203」(味の素株式会社製) 5 質量%
(N−ラウロイルグルタミン酸(フィトステリル/オクチルドデシル))
マカデミアナッツ油 2 質量%
グリセリルトリイソステアレート 2 質量%
δ−トコフェロール 0.01 質量%
サポジトリベースG 2.5 質量%
ベヘニルアルコール 0.25 質量%
ステアリン酸 1 質量%
グリチルレチン酸ステアリル 0.05 質量%
ハ)
ジグリセリン 3 質量%
グリセリン 43.52 質量%
キサンタンガム 0.02 質量%
水 30 質量%
I)
Hydrogenated lecithin 0.3% by mass
Ceramide 2 0.1% by mass
Achillea millefolium extract 0.1% by mass
POE (20) behenyl ether 0.5% by mass
Decaglycerin tristearate 2.22% by mass
Decaglycerin monooleate 2% by mass
Methylparaben 0.2 mass%
Phenoxyethanol 0.5% by mass
Glycerin 2% by mass
B)
Squalane 3% by mass
“El Dew PS203” (manufactured by Ajinomoto Co., Inc.) 5% by mass
(N-lauroyl glutamic acid (phytosteryl / octyldodecyl))
Macadamia nut oil 2% by mass
Glyceryl triisostearate 2% by mass
δ-tocopherol 0.01% by mass
Sapository base G 2.5% by mass
Behenyl alcohol 0.25% by mass
Stearic acid 1% by mass
Stearyl glycyrrhetinate 0.05% by mass
C)
Diglycerin 3% by mass
Glycerin 43.52% by mass
Xanthan gum 0.02% by mass
30% by weight of water
<試験例1>
実施例1〜5、比較例1〜3のポスト・フォーム剤形の温感化粧料について、ポスト・フォーム性を試験した。即ち、37℃に調整したホットプレート上にメスシリンダーを置き、ここに約10mlの内容物を吐出させ、1分後、5分後の体積を計測し、体積増加率(%;(時間経過後の体積−最初の体積)/最初の体積×100)を算出し、ポスト・フォーム性を確かめた。結果を表1に示す。これより、本発明のポスト・フォーム剤形の温感化粧料は適当な時間が経つに従って発泡が進んでいることが判る。これより、本発明の温感化粧料はポスト・フォーム化粧料に適していることが判る。
<Test Example 1>
The post foam properties of the post-foam dosage forms of Examples 1 to 5 and Comparative Examples 1 to 3 were tested. That is, place a graduated cylinder on a hot plate adjusted to 37 ° C., discharge about 10 ml of the contents here, measure the volume after 1 minute and 5 minutes, and increase the volume (%; (after time) Volume-initial volume) / initial volume × 100), and the post foam property was confirmed. The results are shown in Table 1. From this, warming cosmetics of the post-form dosage form of the present invention it can be seen that the foam is progressing in accordance with the appropriate over time. From this, warming cosmetic composition of the present invention is seen to be suitable for the post-form cosmetic.
<試験例2>
実施例1〜5、比較例1〜3のサンプルについて、マッサージング・パックの使用形態に於いて、その温感特性を調べた。即ち、被験者の前腕内側部に化粧料を吐出させ、3分間擦過した後、2分間静置し、化粧料を塗布した皮膚の上面の温度を計測した。結果を表2に示す。本発明のポスト・フォーム剤形の温感化粧料は適度に温かい、適切な温度を保持していることが判る。
<Test Example 2>
About the samples of Examples 1-5 and Comparative Examples 1-3, the warmth characteristic was investigated in the usage form of a massage pack. That is, the cosmetic was discharged onto the inner side of the subject's forearm, rubbed for 3 minutes, allowed to stand for 2 minutes, and the temperature of the upper surface of the skin to which the cosmetic was applied was measured. The results are shown in Table 2. It can be seen that the post-foam dosage form of the present invention is reasonably warm and maintains an appropriate temperature.
<試験例3>
37歳のパネラー(n=1)を用いて、実施例1、比較例2のサンプルを用いて、マッ
サージング・パックを行い、パック前後の唾液中のプラステロン硫酸の量を測定し、パックによるプラステロン硫酸の濃度の増加率を算出した。試験は、検体毎に2回に分けて行った。尚、プラステロン硫酸は、気持ちがよいときほど高濃度唾液中に分泌されることが知られている。プラステロン硫酸はキットを用いて、サンドウィッチ抗体法によって測定した。結果は、実施例1の化粧料の場合が23.4%の増加であり、比較例2の化粧料は9.7%の増加であった。これは、発泡の仕方、及び、温感が適したものであり、これにより、快感を付与しているためであると考えられる。又、この試験より、本発明のポスト・フォーム剤形の温感化粧料が、パック化粧料に好適であることも判る。
<Test Example 3>
Using a 37-year-old panelist (n = 1), the samples of Example 1 and Comparative Example 2 were massaged and the amount of plasterone sulfate in the saliva before and after the pack was measured. The rate of increase in the concentration of plasterone sulfate was calculated. The test was carried out in two times for each specimen. It is known that plasterone sulfate is secreted into high-concentration saliva as it feels better. Plasterone sulfate was measured by a sandwich antibody method using a kit. The result was an increase of 23.4% for the cosmetic of Example 1 and an increase of 9.7% for the cosmetic of Comparative Example 2. This is how the foam, and is than also warming is suitable, thereby, presumably because that impart pleasure. It can also be seen from this test that the post-foam dosage form of the present invention is suitable for pack cosmetics.
本発明は、心地よさをもたらすパック化粧料に応用できる。 The present invention can be applied to pack cosmetics that provide comfort.
Claims (3)
グリセリンの含有量が、前記グリセリン及びジグリセリンから選ばれる成分の合計含有量の90質量%以上であることを特徴とする、ポスト・フォーム剤形の温感化粧料。 1) the total content of components selected from glycerin及beauty diglycerin is 45 to 60 wt%, 2) the content of the fatty acid esters of polyglycerol is 2 to 10 wt%, 3) the content of water 10) 25 to 25 % by weight, and 4 ) a warming cosmetic in a post-form dosage form, characterized in that the content of foaming gas is 1 to 2% by weight ,
A post-form dosage form of a warm cosmetic, wherein the glycerin content is 90% by mass or more of the total content of the components selected from the glycerin and diglycerin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004170884A JP4368250B2 (en) | 2004-06-09 | 2004-06-09 | Post-form dosage form of warm cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004170884A JP4368250B2 (en) | 2004-06-09 | 2004-06-09 | Post-form dosage form of warm cosmetic |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005350378A JP2005350378A (en) | 2005-12-22 |
| JP2005350378A5 JP2005350378A5 (en) | 2007-06-14 |
| JP4368250B2 true JP4368250B2 (en) | 2009-11-18 |
Family
ID=35585152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004170884A Expired - Lifetime JP4368250B2 (en) | 2004-06-09 | 2004-06-09 | Post-form dosage form of warm cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4368250B2 (en) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| JP2007008853A (en) * | 2005-06-30 | 2007-01-18 | Pola Chem Ind Inc | Aerosol cosmetic |
| JP5222465B2 (en) * | 2006-07-07 | 2013-06-26 | ポーラ化成工業株式会社 | Skin external preparation suitable for esthetics |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| WO2009090558A2 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| JP5661253B2 (en) * | 2009-05-18 | 2015-01-28 | 株式会社ダイゾー | Aerosol composition |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| AU2010302350B2 (en) | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| WO2013141263A1 (en) * | 2012-03-22 | 2013-09-26 | 富士フイルム株式会社 | Highly transparent emulsion composition and highly transparent cosmetic |
| JP6504691B2 (en) * | 2014-11-13 | 2019-04-24 | ポーラ化成工業株式会社 | Liquid crystal emulsion composition |
| JP6713255B2 (en) * | 2015-06-23 | 2020-06-24 | ポーラ化成工業株式会社 | LCD cosmetics |
| JP6738141B2 (en) * | 2015-11-24 | 2020-08-12 | 株式会社マンダム | Aerosol cosmetics |
| US10517805B2 (en) | 2015-12-31 | 2019-12-31 | L'oréal | Cosmetic compositions having mechanically activated warming enhancement |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| JP7181646B2 (en) * | 2021-02-08 | 2022-12-01 | 株式会社アイテック | liquid crystal emulsion |
-
2004
- 2004-06-09 JP JP2004170884A patent/JP4368250B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005350378A (en) | 2005-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4368250B2 (en) | Post-form dosage form of warm cosmetic | |
| JP2005350378A5 (en) | ||
| JP4355264B2 (en) | Warm feeling non-water foam cosmetic | |
| US8119109B2 (en) | Foamable compositions, kits and methods for hyperhidrosis | |
| JP2006008574A5 (en) | ||
| US20120156144A1 (en) | Foamable Compositions, Kits and Methods for Hyperhidrosis | |
| JP2009292740A (en) | Cosmetic for blood circulation promotion | |
| JP2009191042A (en) | Skin external preparation in aerosol form | |
| JP2009040738A (en) | Water-in-oil emulsifier type external preparation for skin | |
| JP2006137722A (en) | Foamable cosmetic | |
| JP2010030945A (en) | Foam cosmetic having warm feeling | |
| JP2010030945A5 (en) | ||
| JP2008019230A5 (en) | ||
| JP4185900B2 (en) | Gel cosmetic | |
| JP4338561B2 (en) | Post form cosmetic | |
| JP2007131585A5 (en) | ||
| JP4058399B2 (en) | Cosmetics for exfoliating | |
| JP4491279B2 (en) | Aerosol cosmetics | |
| JP2006001906A (en) | Cosmetic giving warm feeling | |
| JP6013138B2 (en) | Foam aerosol type skin external composition | |
| JP4191012B2 (en) | Foaming fever cosmetic | |
| JP4733965B2 (en) | Warm feeling cosmetics | |
| JP2013023456A (en) | Skin care preparation | |
| JP2005015405A5 (en) | ||
| JP2005162703A (en) | Facial wash |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070420 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070420 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070420 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090514 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090519 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090707 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090804 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090825 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4368250 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150904 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |